catechin has been researched along with Amyloid Neuropathies in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bieschke, J; Boeddrich, A; Ehrnhoefer, DE; Engemann, S; Herbst, M; Lurz, R; Masino, L; Pastore, A; Wanker, EE | 1 |
Roberts, BE; Shorter, J | 1 |
Bieschke, J; Ehrnhoefer, DE; Friedrich, RP; Neugebauer, K; Russ, J; Wanker, EE; Wobst, H | 1 |
3 other study(ies) available for catechin and Amyloid Neuropathies
Article | Year |
---|---|
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers.
Topics: alpha-Synuclein; Amyloid; Amyloid beta-Peptides; Amyloid Neuropathies; Catechin; Humans; Peptide Fragments; Plaque, Amyloid; Protein Binding | 2008 |
Escaping amyloid fate.
Topics: alpha-Synuclein; Amyloid beta-Peptides; Amyloid Neuropathies; Catechin; Humans; Peptide Fragments; Plaque, Amyloid | 2008 |
EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity.
Topics: alpha-Synuclein; Amyloid; Amyloid beta-Peptides; Amyloid Neuropathies; Animals; Blotting, Western; Catechin; CHO Cells; Chromatography, Affinity; Circular Dichroism; Cricetinae; Cricetulus; Escherichia coli; Humans; Microscopy, Atomic Force; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Neuroprotective Agents; PC12 Cells; Rats | 2010 |